Literature DB >> 11139423

Two methods of estimating health costs linked to alcoholism in France (with a note on social costs).

M Reynaud1, A F Gaudin-Colombel.   

Abstract

The health costs of alcohol-related problems in France were estimated using two cost evaluation approaches: (1) estimate based on the proportion of cases attributable to alcohol abuse (the alcohol abuse factor); (2) estimate based on prevalence of alcohol abuse for in- and out-patients. For a 10% prevalence of alcohol abuse in the general population, the minimum cost in 1996 was about US$ 2300 million; for a prevalence of 15% it was US$ 2700 million. This cost concerns the health disorders that are linked directly or indirectly to alcohol abuse. It did not allow for injuries from accidents caused by alcohol intoxication and undervalued the cost of out-patient care. Based on the prevalence of alcohol-related disorders seen at hospitals, a percentage of the total in-patient and out-patient costs due to effects of alcohol could be estimated. However, this did not permit an estimate of the cost of care in which alcohol abuse was a risk factor only. Based on the available data showing that between 3% and 10% of inpatients have a directly alcohol-related condition, estimates of in-patient treatment costs varied from US$ 1300 to 2100 million. Among adult out-patients, 20% present with a disorder in which alcohol is a factor or suffer from an alcohol-related illness, which corresponds to a cost of about US$ 1600 million. Thus, these methods yield minimum year's cost estimated between US$ 2500 and 3300 million. These costs are high, compared to the low level of financing for the specialized facilities offering treatment to people in difficulty due to alcohol excess, which was US$ 23 million in that year. As regards social and total costs, estimates from four Western countries have found that about 75% of the total costs of alcohol abuse was attributable to social harm, and 25% to medical costs. Applying this ratio to the French data gives an estimated total cost to French society of about US$ 13 200 million, i.e. 1.04% of the gross national product.

Entities:  

Mesh:

Year:  2001        PMID: 11139423     DOI: 10.1093/alcalc/36.1.89

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  5 in total

1.  Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.

Authors:  André Pradalier; Jean-Paul Auray; Abdelkader El Hasnaoui; Kazem Alzahouri; Jean-François Dartigues; Gérard Duru; Patrick Henry; Michel Lantéri-Minet; Christian Lucas; Guy Chazot; Anne-François Gaudin
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Direct and indirect costs attributable to alcohol consumption in Germany.

Authors:  Alexander Konnopka; Hans-Helmut König
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 3.  Cost-of-illness studies: concepts, scopes, and methods.

Authors:  Changik Jo
Journal:  Clin Mol Hepatol       Date:  2014-12-24

4.  Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy.

Authors:  Giorgio L Colombo; Sergio Di Matteo; Giacomo Bruno
Journal:  Subst Abuse Rehabil       Date:  2012-07-17

5.  Production Losses Associated with Alcohol-Attributable Mortality in the European Union.

Authors:  Błażej Łyszczarz
Journal:  Int J Environ Res Public Health       Date:  2019-09-21       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.